Schizophrenia

Schizophrenia: symptoms, diagnosis and treatment

How pharmacists can recognise the signs and symptoms of schizophrenia — a psychotic condition that affects more than 685,000 people in the UK — with an overview of treatment options, side effects and management advice.…

Schizophrenia drug shortage affecting patient care, College of Mental Health Pharmacy warns

Supplies of aripiprazole 10mg tablets are low until late August 2022 and there is "limited scope for alternatives".…

COVID-19 vaccination could cause ‘red’ results in clozapine monitoring, pharmacists warn

Exclusive: Mental health pharmacists say that clozapine treatment has been discontinued in some patients because of a reduction in white blood cells following infection with COVID-19, but interrupting treatment is not necessarily the right course of action.…

Schizophrenia: recognition and management

Common medicines used to manage schizophrenia have many side effects that can cause significant morbidity. Regular monitoring and support can ensure patients improve outcomes.…

Cognitive cannabis: the emerging evidence for treating mental health problems

One year since UK law changed to enable medical cannabis to be prescribed, researchers are exploring the drug’s potential for treating post-traumatic stress disorder, schizophrenia and attention deficit hyperactivity disorder.…

We need to talk about severe mental illness, RPS Hertfordshire and Bedfordshire event hears

The average life expectancy of people with severe mental illness is 15–20 years shorter than those without and, to change this, we need to do things differently.…

Patient perspective of a pilot pharmacist-led medicines and health education programme for mental health

Psychoeducation is the education of a person with a psychiatric disorder regarding the symptoms, treatments and prognosis of their illness[1] . There is evidence to suggest that it can improve outcomes for patients with mental health conditions[2] . A Cochrane review on psychoeduca…

FDA approves first digital pill

The first pill which can be digitally tracked as it makes its way through the body has been approved for use by the US safety drugs watchdog, the Food and Drug Administration.…

Trial begins to investigate efficacy of monoclonal antibody against schizophrenia

A two-year trial has begun to analyse the efficacy of a monoclonal antibody drug, currently used to treat multiple sclerosis, as a treatment for schizophrenia.…

Study finds disparity between antipsychotics in preventing schizophrenia relapses

There are big differences in antipsychotic agents in terms of failure of treatment and risk of rehospitalisation among patients with schizophrenia.…